Cencora Inc (BSP:C1CO34)
R$ 717.12 0 (0%) Market Cap: 277.21 Bil Enterprise Value: 285.61 Bil PE Ratio: 33.25 PB Ratio: 75.37 GF Score: 85/100

Cencora Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 12, 2023 / 04:50PM GMT
Release Date Price: R$436.92
Eric White Coldwell
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Good afternoon, everyone. My name is Eric Coldwell. I cover pharma distribution and health care services at Baird, and it's our pleasure to have -- I almost said AmerisourceBergen again, Jim, it's just such an old habit; Cencora, with us today. And that is a very recent name change and ticker change. So hopefully, we do a great job of branding and marketing exercises here for the rest of the session.

We have Jim Cleary with us, of course; CFO, Bennett Murphy in Investor Relations. This has been one of our top ideas for a number of years. We got back involved in the drug distribution space in February of 2020. ABC has been either a formal best idea or one of the communicated best ideas ever since that point.

And we have a very long history, I think it's that ABC again, which is -- I was just going to be habit. I'm going to do it until I don't. I don't have a big formal intro, but I wanted to ask you if you wanted to jump in with any initial commentary, Jim, before we get going or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot